Skip to main content
Log in

Comparison of two different loading doses of digoxin in severe renal impairment

  • Original
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The correct loading dose of digoxin in patients with advanced renal failure is still a matter of discussion. The effect has been studied of loading doses of digoxin 0.625 mg or 1.25 mg given over 48 h according to randomized crossover design to healthy volunteers and to two different groups of patients with renal impairment and the same mean endogenous creatinine clearance of about 15 ml/min. The subsequent maintenance dose for 4 days was digoxin 0.25 mg in the volunteers and 0.125 mg in both groups of patients. The minimum plasma digoxin concentrations before each dose was measured by radioimmunoassay and the plasma levels in the different groups have been compared. In the healthy volunteers no significant difference was found during the study, despite wide variation in the plasma digoxin concentration. In contrast, in patients with renal failure, the group with the higher loading dose showed significantly higher plasma concentrations 24, 36 and 48 h after drug administration, reaching the highest mean value of 2.2 ng/ml at 48 h. However, after 120 h of maintenance therapy a mean digoxin concentration of 1.3 mg/ml was found in both groups. Thus, despite different loading doses identical plasma concentrations were reached during administration of the same maintenance therapy. The higher plasma digoxin concentration obtained during administration of a higher loading dose might be the cause of arrythmias in individual patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beveridge T, Nüesch E, Ohnhaus EE (1978) Absolute bioavailability of digoxin tablets. Arzneim Forsch (Drug Res) 28: 701–703

    Google Scholar 

  • Chamberlain DA, White RJ, Howard MR, Smith TW (1970) Plasma digoxin concentrations in patients with atrial fibrillation. Br Med J 3: 429–432

    PubMed  Google Scholar 

  • Chung EK (1969) Digitalis intoxication. Williams and Wilkins, Baltimore, pp 1–2

    Google Scholar 

  • Dengler HJ, Bodem G, Wirth K (1973) Pharmacokinetic and metabolic studies with lanhatoside C, α- and β-acetyldigoxin and digoxin in man. Pharmacology and the future of man. Proc 5th Int Congr Pharmacology San Francisco 1972, Vol 3. Karger, Basel, pp 112–126

    Google Scholar 

  • Evered DC, Chapman C (1971) Plasma digoxin concentrations and digoxin toxicity in hospital patients. Br Heart J 33: 540–545

    PubMed  Google Scholar 

  • Greenblatt DJ, Smith TW, Koch-Weser J (1976) Bioavailability of drugs/ the digoxin dilemma. Clin Pharmacokinet 1: 36–51

    PubMed  Google Scholar 

  • Jeliffe RW (1968) An improved method of digoxin therapy. Ann Intern Med 69: 703–717

    PubMed  Google Scholar 

  • Johnston GD, Harron WG, McDevitt DG (1979) Can digoxin prescribing be improved? A comparison between intuitive and assisted dose selection. Eur J Clin Pharmacol 16: 229–235

    Google Scholar 

  • Koup JR, Greenblatt DJ, Jusko WJ, Smith TW, Koch-Weser J (1975a) Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. J Pharmacokinet Biopharm 3: 181–192

    PubMed  Google Scholar 

  • Koup JR, Jusko WJ, Elwood CM, Kohli RK (1975b) Digoxin Pharmacokinetics: Role of renal failure in dosage regimen design. Clin Pharmacol Ther 18: 9–21

    PubMed  Google Scholar 

  • Nyberg L, Anderson KE, Bertler A (1974) Bioavailability of digoxin from tablets: II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration. Acta Pharm Suec 2: 459–470

    Google Scholar 

  • Ohnhaus EE, Vozeh S, Nüesch E (1979a) Absorption of digoxin in severe right heart failure. Eur J Clin Pharmacol 15: 115–120

    PubMed  Google Scholar 

  • Ohnhaus EE, Vozeh S, Nüesch E (1979b) Absolute bioavailability of digoxin in chronic renal failure. Clin Nephrol 11: 302–306

    PubMed  Google Scholar 

  • Rabkin SW, Grupp G (1975) A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses. Acta Cardiol 30: 343–351

    PubMed  Google Scholar 

  • Reuning RH, Sams RA, Notari RE (1973) Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologie effect kinetics and apparent volume of distribution. J Clin Pharmacol 13: 127–141 (1973)

    Google Scholar 

  • Sachs L (1978) Angewandte Statistik. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Wagner JG (1974) Loading and maintenance doses of digoxin in patients with normal renal function and those with severly impaired renal function. J Clin Pharmacol 14: 329–338

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohnhaus, E.E., Lenzinger, H.R. & Galeazzi, R.L. Comparison of two different loading doses of digoxin in severe renal impairment. Eur J Clin Pharmacol 18, 467–472 (1980). https://doi.org/10.1007/BF00874657

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00874657

Key words

Navigation